Published in Am Heart J on August 01, 2004
Dyslipidaemia as a predictor of hypertension in middle-aged men. Eur Heart J (2008) 0.93
Are statins effective for simultaneously treating dyslipidemias and hypertension? Atherosclerosis (2007) 0.88
Improvement of age-related endothelial dysfunction by simvastatin: effect on NO and COX pathways. Br J Pharmacol (2005) 0.87
Hypotensive effect of atorvastatin in hypertensive patients: the association among flow-mediated dilation, oxidative stress and endothelial dysfunction. Arch Med Sci (2011) 0.86
Membrane tension modulates the effects of apical cholesterol on the renal epithelial sodium channel. J Membr Biol (2007) 0.84
Use of statins and blood pressure. Am J Hypertens (2007) 0.83
LIPITENSION: Interplay between dyslipidemia and hypertension. Indian J Endocrinol Metab (2012) 0.82
Simvastatin induces a central hypotensive effect via Ras-mediated signalling to cause eNOS up-regulation. Br J Pharmacol (2013) 0.79
Blood pressure-lowering effect of simvastatin: a placebo-controlled randomized clinical trial with 24-h ambulatory blood pressure monitoring. J Hum Hypertens (2013) 0.78
Statin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP? Curr Atheroscler Rep (2011) 0.78
Changes in lipids and lipoprotein indices in relation to the severity of hypertension in newly diagnosed hypertensive nigerians. ISRN Cardiol (2012) 0.77
Omega-3 polyunsaturated fatty acids: Their potential role in blood pressure prevention and management. Heart Int (2006) 0.77
Probiotics Blunt the Anti-Hypertensive Effect of Blueberry Feeding in Hypertensive Rats without Altering Hippuric Acid Production. PLoS One (2015) 0.76
Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study. PLoS One (2016) 0.75
Influence of dyslipidemia in control of arterial hypertension among type-2 diabetics in the western region of the Republic of Macedonia. Am J Cardiovasc Dis (2014) 0.75
The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. Ann Intern Med (2006) 3.05
Surgical menopause increases salt sensitivity of blood pressure. Hypertension (2006) 2.38
Riskard 2005. New tools for prediction of cardiovascular disease risk derived from Italian population studies. Nutr Metab Cardiovasc Dis (2005) 1.65
Relative role of systolic, diastolic and pulse pressure as risk factors for cardiovascular events in the Brisighella Heart Study. J Hypertens (2002) 1.51
Persistence of treatment and blood pressure control in elderly hypertensive patients treated with different classes of antihypertensive drugs. Am J Geriatr Cardiol (2007) 1.48
The burden of narcolepsy with cataplexy: how disease history and clinical features influence socio-economic outcomes. Sleep Med (2012) 1.46
Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project). World J Gastroenterol (2008) 1.31
Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients. Kidney Int (2002) 1.03
Which is the best MRI marker of malignancy for atypical cirrhotic nodules: hypointensity in hepatobiliary phase alone or combined with other features? Classification after Gd-EOB-DTPA administration. J Magn Reson Imaging (2012) 0.99
Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy. Eur J Clin Pharmacol (2008) 0.98
VDR expression on circulating endothelial progenitor cells in dialysis patients is modulated by 25(OH)D serum levels and calcitriol therapy. Blood Purif (2011) 0.92
Effect of olive oils on biomarkers of oxidative DNA stress in Northern and Southern Europeans. FASEB J (2006) 0.92
The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus. Clin Ther (2003) 0.90
A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice. Vasc Health Risk Manag (2007) 0.90
A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome. Diabetes Res Clin Pract (2004) 0.89
Improved tolerability of the dihydropyridine calcium-channel antagonist lercanidipine: the lercanidipine challenge trial. Blood Press Suppl (2003) 0.87
Trends in blood pressure control and antihypertensive treatment in clinical practice: the Brisighella Heart Study. J Hypertens (2004) 0.87
Coronary calcifications in end-stage renal disease patients: a new link between osteoprotegerin, diabetes and body mass index? Blood Purif (2009) 0.86
Non-pharmacological control of plasma cholesterol levels. Nutr Metab Cardiovasc Dis (2008) 0.86
Evaluation of persistence and adherence to teriparatide treatment in patients affected by severe osteoporosis (PATT): a multicenter observational real life study. Clin Cases Miner Bone Metab (2013) 0.86
Tinnitus in elderly patients and prognosis of mild-to-moderate congestive heart failure: a cross-sectional study with a long-term extension of the clinical follow-up. BMC Med (2011) 0.85
Effects of the early ACE inhibition in diabetic nonthrombolyzed patients with anterior acute myocardial infarction. Diabetes Care (2003) 0.84
Long-term effect of a dietary education program on postmenopausal cardiovascular risk and metabolic syndrome: the Brisighella Heart Study. J Womens Health (Larchmt) (2010) 0.83
Effects of a new soy/beta-sitosterol supplement on plasma lipids in moderately hypercholesterolemic subjects. J Am Diet Assoc (2002) 0.83
Serum cholesterol levels, blood pressure response to stress and incidence of stable hypertension in young subjects with high normal blood pressure. J Hypertens (2004) 0.82
The relationship between systolic blood pressure and cardiovascular risk--results of the Brisighella Heart Study. J Clin Hypertens (Greenwich) (2003) 0.82
Use of lipid-lowering drugs and blood pressure control in patients with arterial hypertension. J Clin Hypertens (Greenwich) (2002) 0.81
5-methyltetrahydrofolate administration is associated with prolonged survival and reduced inflammation in ESRD patients. Am J Nephrol (2008) 0.81
Effect of vitamin D receptor activator therapy on vitamin D receptor and osteocalcin expression in circulating endothelial progenitor cells of hemodialysis patients. Blood Purif (2013) 0.81
Combined lipoxygenase/cyclo-oxygenase inhibition in the elderly: the example of licofelone. Drugs Aging (2005) 0.80
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride. Hypertens Res (2005) 0.80
Hemodynamic effects of lactotripeptides from casein hydrolysate in Mediterranean normotensive subjects and patients with high-normal blood pressure: a randomized, double-blind, crossover clinical trial. J Med Food (2010) 0.78
Interaction between serum cholesterol levels and the renin-angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure. J Hypertens (2007) 0.78
Short- and Long-Term Stroke Risk after Urgent Management of Transient Ischaemic Attack: The Bologna TIA Clinical Pathway. Eur Neurol (2015) 0.78
Clinical role of Natrilix SR in the treatment of at-risk hypertensive patients. J Hypertens Suppl (2003) 0.78
Effects of AT1 receptor and beta1 receptor blocking on blood pressure, peripheral hemodynamic and lipid profile in statin-treated hypertensive hypercholesterolemic patients. Fundam Clin Pharmacol (2009) 0.77
Effects of doxazosin and irbesartan on blood pressure and metabolic control in patients with type 2 diabetes and hypertension. J Cardiovasc Pharmacol (2005) 0.77
Effects of unfractioned heparin and low-molecular-weight heparin on osteoprotegerin and RANKL plasma levels in haemodialysis patients. Nephrol Dial Transplant (2010) 0.77
Serum lipopotein (a) levels in a large sample of subjects affected by familial combined hyperlipoproteinaemia and in general population. J Cardiovasc Risk (2003) 0.76
Persistence on treatment and blood pressure control with different first-line antihypertensive treatments: a prospective evaluation. Clin Exp Hypertens (2007) 0.76
The impact of apoptosis and inflammation gene polymorphisms on transplanted kidney function. Ann Transplant (2013) 0.75
Compliance with therapy in hypertensive patients. Intern Emerg Med (2006) 0.75
Asymptomatic massive hypertriglyceridemia in an octogenarian. Med Princ Pract (2003) 0.75
Factors associated with nurses' opinions and practices regarding information and consent. Nurs Ethics (2013) 0.75
The treatment of hypertension in pregnancy. J Hypertens Suppl (2002) 0.75
Effect of monochloramine treatment on colonization of a hospital water distribution system by Legionella spp.: a 1 year experience study. Environ Sci Technol (2015) 0.75
[Health profile of a population as a predictor of health resources utilization: results of the implementation of an epidemiologic model for needs analysis]. Epidemiol Prev (2004) 0.75
Otoscopic examination: a diagnostic contribution for atherosclerotic disease? Med Hypotheses (2008) 0.75
Improving donor identification with the Donor Action programme. Transpl Int (2002) 0.75
It is necessary to prevent a cerebrovascular 'pandemia'. Cerebrovasc Dis (2003) 0.75
Effects of a new low dose soy protein/beta-sitosterol association on plasma lipid levels and oxidation. Eur J Nutr (2004) 0.75
Donor Action program in the Emilia-Romagna region of Italy. Prog Transplant (2002) 0.75
Lipid-lowering treatment in patients at high cardiovascular risk discharged from an Italian hospital. J Cardiovasc Med (Hagerstown) (2013) 0.75
[Hypercholesterolemia as cardiovascular risk in hypertensive patients. Therapeutic implications: efficiency of statins]. Recenti Prog Med (2003) 0.75
Relationship between blood pressure, cholesterolemia and serum apolipoprotein B in a large population sample: the Brisighella Heart Study. J Hypertens (2012) 0.75
Recognition of elder abuse by Italian nurses and nursing students: evaluation by the Caregiving Scenario Questionnaire. Aging Clin Exp Res (2013) 0.75